SCHEMBL19895161

SCHEMBL19895161

COC(=O)c1ccc(-c2ccc(Cl)cc2)nc1C(C)Br

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.65
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
MAPT P10636 3/20 0.65
L3MBTL1 Q9Y468 2/20 0.65
NFKB1 P19838 1/20 0.65
NFKB2 Q00653 1/20 0.65
RELA Q04206 1/20 0.65
SLC6A3 Q01959 5/20 0.49
SLC6A4 P31645 1/20 0.49
CASP3 P42574 2/20 0.48
SENP8 Q96LD8 2/20 0.48
SENP7 Q9BQF6 2/20 0.48
SENP6 Q9GZR1 2/20 0.48
PLA2G2A P14555 1/20 0.44
ABL1 P00519 1/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 3/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19895163 0.87 PLA2G2A (0.50) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL19895199 0.86 NPC1 (0.47) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL29419183 0.85 NPC1 (0.47) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL19895185 0.85 NPC1 (0.47) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL19895205 0.85 RAB9A (0.46) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL19895160 0.84 NPC1 (0.45) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL27273159 0.80 TUBB4A (0.47) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL19895176 0.80 CYP19A1 (0.46) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL29419189 0.80 CYP19A1 (0.46) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL19808864 0.80 P2RX3 (0.43) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108884047-B Intermediates for the synthesis of aryl or heteroaryl substituted 5-hydroxy-1, 7-naphthyridine compounds and methods for their preparation 沈阳三生制药有限责任公司 2022-03-08 CN disclosed
EP-3287456-B1 COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYL OR HETEROARYL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF SHENYANG SUNSHINE PHARMACEUTICAL CO LTD (CN) 2020-08-26 EP disclosed
US-9994566-B2 Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD. (CN) 2018-06-12 US disclosed
US-20180118738-A1 COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYL OR HETEROARYL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. (CN) 2018-05-03 US disclosed
EP-3287456-A1 COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYL OR HETEROARYL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF Shenyang Sunshine Pharmaceutical Co., Ltd. (CN) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118738-A1 COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYL OR HETEROARYL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF HIF1AN, EGLN3, EGLN2 SMN1; SMN2 3960/4885NPC1 1246/4885RAB9A 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.